Blexten (BLEKS-ten, bilastine) and Rupall (ROO-pal, rupatadine) are two new antihistamines on prescription. "BLEXTEN (bilastine 20 mg oral tablet) is a second generation antihistamine drug for the treatment of Seasonal Allergic Rhinitis (SAR) and Chronic Spontaneous Urticaria (CSU). BLEXTEN exerts its effect as a selective histamine H1 receptor antagonist, and has an effectiveness comparable to cetirizine, fexofenadine and desloratadine." "Rupatadine is a new second-generation antihistamine and platelet-activating factor (PAF) antagonist." Blexten DIN is 2454130 Rupall DIN is 2456451 You can also read more on Canadian Pharmacist's Letter; February 2017; Vol: 33 |
News ArticlesNews that has been personally selected by the Editorial team. Archives
September 2021
Categories |